Chairman, Digestive Disease Institute Cleveland Clinic
General Surgery
Dr. John J. Fung, MD
|
|
Give Review
John Fung is an expert in the field of General Surgery. He researched medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification", "TTS-Roche Award for Worldwide Impact in Transplantation", "ILTS Distinguished Service Award", "Chinese American Medical Society Scientific Achievement Award", "Northern Ohio Live", "Kate and Harvey Cushing Lecturer", "ASTS Francis Moore Excellence in Mentorship Award", "AASLD Thomas Starzl State-of-the-Art Liver Transplant Lecturer", "AASLD Achievement in Liver Transplantation Award", "Listing in the Institute for Scientific Information Highly Cited Rating", "Assistant Professorship in Transplant Surgery", "Hopeman Lecturer", "Ronald W. Fish Humanitarian of the Year Award", "AST/Novartis Clinical Science Award", "Honorary Professor", "Albert Humanitarian Award", "Vectors Pittsburgh Man of the Year Honor", "Annual Gift of Life Award", "UNOS Scientific Advisory Committee Outstanding Service Award", "Irvington Institute for Medical Research Fellow in Immunology", "Outstanding Scientific Paper Award", "Upjohn Award for Outstanding Research as Resident in Surgery", "Research Fellowship", "Recipient of Competitive Medical Research Fund", "Recipient of Young Investigator Bursary", "Fellow (FACS)" and "Thomas Starzl Prize in Surgery and Immunology". Doctor John J. Fung, MD is also a published physician. He has 102 paper published. The most recent paper is: Risk stratification of allograft failure secondary to hepatitis C recurrence after liver transplantation. Doctor John J. Fung, MD is registered with Medicare and accepts Medicare payments.
Publications
- Risk stratification of alloGraft failure secondary to hepatitis C recurrence after liver transplantation.
- Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death-Ligand 1.
- Oncologic results of laparoscopic Liver resection for malignant Liver tumors.
- Prognostic Role of Plasma Vascular Endothelial Growth Factor in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
- Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis.
- All-trans Retinoic Acid Induces Arginase-1 and Inducible Nitric Oxide Synthase-Producing Dendritic Cells with T Cell Inhibitory Function.
- Post-Liver transplantation sarcopenia in cirrhosis: a prospective evaluation.
- Ex Vivo Normothermic Machine Perfusion Is Safe, Simple, and Reliable: Results From a Large Animal Model.
- Oxygen consumption predicts outcome in porcine partial liver Grafts.
- The successful use of telaprevir to treat hepatitis C recurrence after Liver transplantation in an HIV co-infected patient.
- KIR and HLA interactions are associated with control of primary CMV infection in solid organ transplant recipients.
- Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma.
- Transfusion of older red blood cells is associated with decreased Graft survival after orthotopic liver transplantation.
- The prognostic value of kidney transplant center report cards.
- Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary coloRectal liver metastasis.
- Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway.
- Renal function at two years in Liver transplant patients receiving everolimus: results of a randomized, multicenter study.
- Laparoscopic versus open resection of coloRectal liver metastasis.
- Splenic artery embolization for the treatment of refractory ascites after Liver transplantation.
- Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoRegional therapies.
- Liver transplant outcomes in HIV+ haemophilic men.
- The association of center performance evaluations and kidney transplant volume in the United States.
- The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells.
- Combined Heart and Liver Transplantation: The Cleveland Clinic Experience.
- Tolerance-inducing strategies in islet transplantation.
- Predicting the discharge status after Liver transplantation at a single center: a new approach for a new era.
- Heart transplantation research in the next decade-a goal to achieving evidence-based outcomes: national heart, lung, and blood institute working group.
- Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation Is Associated With Reduced Need For Colectomy In Patients With Ulcerative Colitis.
- Myeloid-Derived Suppressor Cells Protect Islet Transplants By B7-H1 Mediated Enhancement of T Regulatory Cells.
- Hepatic blood flow plays an important role in ischemia-reperfusion injury.
- Stromal cell-based immunotherapy in transplantation.
- The Role of the A2a Receptor Agonist, Regadenoson, in Modulating Hepatic Artery Flow in the Porcine Small-for-Size Liver Graft.
- Present state of immunosuppressive therapy in Liver transplant recipients.
- Future prospects in Liver transplant immunosuppression.
- Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.
- Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice.
- The role of Liver stromal cells in dendritic cells development in mice.
- Elevated Catecholamines and Hepatic Artery Vasospasm in Porcine Small-for-Size Liver Graft.
- Deep hypothermia with circulatory arrest to aid in the management of suprahepatic vena cava stenosis after Liver transplantation.
- Use of tissue plasminogen activator in Liver transplantation from donation after cardiac death donors.
- Is impaired hepatic arterial buffer response a risk factor for Biliary anastomotic stricture in liver transplant recipients?
- Glucose balance of porcine liver alloGraft is an important predictor of outcome.
- Themes of Liver transplantation.
- A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet alloGraft rejection.
- Liver transplantation in the United States, 1999-2008.
- Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling.
- Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small-for-size syndrome.
- Distinct response of Liver myeloid dendritic cells to endotoxin is mediated by IL-27.
- Transplant innovation and ethical challenges: what have we learned? A collection of perspectives and panel discussion.
- Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation.
- New technique in hepatic parenchymal transection for living related Liver donor and Liver neoplasms.
- Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt.
- Association between donor-recipient serum sodium differences and orthotopic liver transplant Graft function.
- Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic Liver transplantation.
- Using Livers from donation after cardiac death donors--a proposal to protect the true Achilles heel.
- World's longest surviving Liver-pancreas recipient.
- Can partial auxiliary liver transplantation protect kidney Grafts in highly sensitized patients?
- Growth factor-induced mobilization of dendritic cells in kidney and Liver of rhesus macaques: implications for transplantation.
- Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells.
- Dental health status of Liver transplant candidates.
- Liver transplantation in China.
- The role of Liver-derived regulatory dendritic cells in prevention of type 1 diabetes.
- Cotransplanted hepatic stellate cells enhance vascularization of islet alloGrafts.
- ICAM-1 expressed on hepatic stellate cells plays an important role in immune regulation.
- Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.
- In vivo expansion of two distinct dendritic cells in mouse Livers and its impact on Liver immune regulation.
- Animal activism and intimidation of scientists.
- In vivo immune modulatory activity of hepatic stellate cells in mice.
- Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome.
- Isolated right hepatic vein Obstruction after piggyback liver transplantation.
- Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver Disease.
- Expanding the donor pool: safe transplantation of a cadaveric liver alloGraft with a 10 cm cavernous hemangioma--a case report.
- Caroli's Disease and orthotopic liver transplantation.
- Mechanistic insights into achievement of cardiac alloGraft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.
- Preservation solutions in Liver transplantation: what are the options?
- A randomized trial of inhaled cyclosporine in lung-transplant recipients.
- Immune regulatory activity of Liver-derived dendritic cells generated in vivo.
- Regulatory dendritic cells modulate immune responses via induction of T-cell apoptotic death.
- Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single...
- Immunosuppression for Liver transplantation in HCV-infected patients: mechanism-based principles.
- Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver Disease.
- Effect of age and postoperative time on cytochrome p450 enzyme activity following Liver transplantation.
- Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.
- Prolongation of cardiac alloGraft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.
- Augmentation of type-1 polarizing ability of monocyte-derived dendritic cells from chronically immunosuppressed organ-transplant recipients.
- Revascularization of the gastroduodenal artery in a pancreas alloGraft from a donor with a replaced right hepatic artery.
- Preliminary report on surgical technique in hepatic parenchymal transection for Liver tumors in the elderly: a lesson learned from living-related Liver transplantation.
- Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary ex...
- Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice.
- Use of alemtuzumab and tacrolimus monotherapy for cadaveric Liver transplantation: with particular reference to hepatitis C virus.
- De novo malignancies after Intestinal and multivisceral transplantation.
- Tacrolimus and transplantation: a decade in review.
- Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience.
- Lessons of organ-induced tolerance learned from historical clinical experience.
- Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway.
- Porcine partial liver transplantation: a novel model of the "small-for-size" liver Graft.
- Progression of Liver fibrosis in patients with chronic hepatitis C after orthotopic Liver transplantation.
- Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
- Pregnancy after Liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years.
- Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in Liver transplantation patients.
- Liver transplantation for nonalcoholic steatohepatitis in young patients.
Schools
University Of ChicagoThe Pritzker School Of Medicine
Strong Memorial Hospital
University Pittsburgh
Procedures Preformed
- Gallbladder Removal (Cholecystectomy), Laparoscopic
- Hepatectomy
- Intestinal Transplant (incl. Enterectomy)
- Laparoscopic Tumor Ablation, Liver
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- Biliary Atresia
- Cholecystitis and Gallstones
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- TTS-Roche Award for Worldwide Impact in Transplantation
- ILTS Distinguished Service Award
- Chinese American Medical Society Scientific Achievement Award
- Northern Ohio Live
- Kate and Harvey Cushing Lecturer
- ASTS Francis Moore Excellence in Mentorship Award
- AASLD Thomas Starzl State-of-the-Art Liver Transplant Lecturer
- AASLD Achievement in Liver Transplantation Award
- Listing in the Institute for Scientific Information – Highly Cited Rating
- Assistant Professorship in Transplant Surgery
- Hopeman Lecturer
- Ronald W. Fish Humanitarian of the Year Award
- AST/Novartis Clinical Science Award
- Honorary Professor
- Albert Humanitarian Award
- Vectors Pittsburgh Man of the Year Honor
- Annual Gift of Life Award
- UNOS Scientific Advisory Committee Outstanding Service Award
- Irvington Institute for Medical Research Fellow in Immunology
- Outstanding Scientific Paper Award
- Upjohn Award for Outstanding Research as Resident in Surgery
- Research Fellowship
- Recipient of Competitive Medical Research Fund
- Recipient of Young Investigator Bursary
- Fellow (FACS)
- Thomas Starzl Prize in Surgery and Immunology
Education
-
University of Pittsburgh Medical Center -
University of Rochester -
University of Chicago Pritzker School of Medicine -
University of Chicago -
Johns Hopkins University
Hospital
-
Cleveland Clinic -
Cleveland Clinic Florida
Drug Facts
| NPI NUMBER | 1235293622 | |
| NPPES Provider LastName | FUNG | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | General Surgery | |
| Total Claim Count | 42.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235293622 |
| Last Name Of The Provider | FUNG |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Matthew F. Kalady, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Harry L. Reynolds Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexis Grucela, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melanie A. Lynch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew Eagleton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Kiely, MD |
|
|
Dr. Stanley O. Hoerr, MD |
|
|
Dr. Daniel G. Clair, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Raymond P. Onders, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Juan R. Sanabria, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tamer S. Attia, MD |
|
|
Dr. Yuanyuan Gu, MD |
|
|
Dr. Anand R. Kalepu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacquelyn D. Urban, MD
This Doctor is OpenDoctor Recommended.
|